← Leaderboards
James S Floyd
University Of Washington
$14,044,052
Attributed
$29,085,254
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.9M · FY2013–25$20M$15M$10M$5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,085,254 · 7
By mechanism
U24$16,636,716 · 1
R01$11,742,383 · 5
K08$706,155 · 1
Top collaborators
- Garnet L. Anderson6 shared
- Kwun Chuen Gary Chan6 shared
- Robert C Kaplan6 shared
- Michelle Christina Odden2 shared
- Lin Yee Chen1 shared
- Wt Longstreth1 shared
- Bruce M Psaty1 shared
- Amil M Shah1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Susan Heckbert$14,216,326
- Bobbie A Berkowitz$0
- Kwun Chuen Gary Chan$6,551,274
- Wt Longstreth$6,269,140
- Bhagwat Prasad$6,430,223
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesCardiovascular SystemParticipantPopulation BasedPharmaceutical PreparationsLeadHeart FailureCohortStrokeEventCardiovascular Risk FactorCessation Of LifeFundingFollow-UpCohort StudiesAtrial FibrillationMyocardial InfarctionJackson Heart StudyCardiovascular Disorder PreventionRisk FactorsNational Heart, Lung, And Blood InstituteDesignMedical RecordsCardiovascular Disorder Risk
Grant awards (23)
Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$8,753,539
U24 · FY2025 · HL
Proteomic and Genomic Discovery of Targets for Atrial Cardiopathy-Related Cardiovascular Outcomes$1,657,473
R01 · FY2025 · HL · contact PI
Infrastructure for mentored access to CHS data and specimens$1,372,795
R01 · FY2025 · HL
Proteomic profiling to identify mechanisms of susceptibility and resilience to cardiac dysfunction in Black Americans$815,229
R01 · FY2025 · HL
MOSAAIC Cognitive Assessment Reading Center Administrative Supplement$299,670
U24 · FY2025 · HL
Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$4,168,697
U24 · FY2024 · HL
Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement for PBMCs and RNA PaxGene$441,897
U24 · FY2024 · HL
Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement$372,945
U24 · FY2024 · HL
Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$2,599,968
U24 · FY2023 · HL
Proteomic discovery in an inception cohort of acute myocardial infarction survivors$693,268
R01 · FY2023 · HL · contact PI
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study$822,400
R01 · FY2022 · HL · contact PI
Proteomic discovery in an inception cohort of acute myocardial infarction survivors$737,881
R01 · FY2022 · HL · contact PI
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study$1,042,792
R01 · FY2021 · HL · contact PI
Proteomic discovery in an inception cohort of acute myocardial infarction survivors$795,459
R01 · FY2021 · HL · contact PI
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study$998,176
R01 · FY2020 · HL · contact PI
Proteomic discovery in an inception cohort of acute myocardial infarction survivors$811,511
R01 · FY2020 · HL · contact PI
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study$988,744
R01 · FY2019 · HL · contact PI
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study$1,006,655
R01 · FY2018 · HL · contact PI
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus$159,151
K08 · FY2017 · HL · contact PI
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus$161,024
K08 · FY2016 · HL · contact PI
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus$127,860
K08 · FY2015 · HL · contact PI
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus$128,331
K08 · FY2014 · HL · contact PI
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus$129,789
K08 · FY2013 · HL · contact PI